Accretion Pharmaceuticals IPO Listing
Accretion Pharmaceuticals IPO Listing Status
Accretion Pharmaceuticals IPO Listing date is 21 May 2025. Subscription closed at 7.67x times; allotment completed on 19 May 2025 by registrar Kfin Technologies Limited. Shares are listed on NSE EMERGE on 21 May 2025 at 9:15 AM.
On NSE, shares of Accretion Pharmaceuticals IPO are listed at ₹79.00 for a discount of 21.78%.
Accretion Pharmaceuticals IPO is a Book Building issue of ₹29.75 Crore, offering about 29.46 Lakh to the public.
This IPO is a complete Fresh Issue of 29.46 Lakh shares worth ₹29.75 Crore.
Accretion Pharmaceuticals IPO Listing Status Overview
| Accretion Pharmaceuticals IPO Listing | NSE |
|---|---|
| Symbol | ACCPL |
| Issue Price | ₹101 |
| Listing Price | ₹79.00 |
| Listing Gains | -21.78% |
| Listing Day High | 82.95 |
| Listing Day Low | 75.05 |
| Listing Day Close | 82.95 |
| Volume of Trade | 658800 |
Accretion Pharmaceuticals IPO Minimum Returns
The table below shows the minimum returns a successfully subscribed and allotted Accretion Pharmaceuticals IPO investor may receive, based on the subscription status of each category and the listing prices on NSE EMERGE.
| Application | Min Amount | Min Returns (NSE) |
|---|---|---|
| Retail Minimum | ₹121200 | -₹26398 Loss |
| Retail Maximum | ₹121200 | -₹26398 Loss |
| SHNI Minimum | ₹56624 | -₹12333 Loss |
| SHNI Maximum | ₹113249 | -₹24666 Loss |
| BHNI Minimum | ₹141561 | -₹30832 Loss |
| BHNI Maximum | ₹254810 | -₹55498 Loss |
| QIB Minimum | ₹99868 | -₹21752 Loss |
Accretion Pharmaceuticals Limited IPO (Accretion Pharmaceuticals IPO) Overview
| IPO Name | Accretion Pharmaceuticals Limited IPO |
| IPO Status | Listed on NSE at INR 79 (-21.78%) |
| IPO Open Date | 14 May 2025 |
| IPO Close Date | 16 May 2025 |
| Face Value | ₹10 Per Equity Share |
| One Lot Size | 1200 Equity Shares |
| Total Issue | 29,46,000 Shares (worth up to ₹29.75 Crore Rs) |
| Fresh Issue | 29,46,000 Shares (worth up to ₹29.75 Crore Rs) |
| Issue Type | Book Building Issue |
| IPO Listing | NSE EMERGE |
| Retail Portion | Up to 35% of Net Issue |
| NII Portion | Up to 15% of Net Issue |
| Net QIB Portion | Up to 20% of Net Issue |
| Anchor Portion | Up to 30% of Net Issue |
| DRHP Draft Prospectus | View DRHP |
| RHP Draft Prospectus | View RHP |
| Anchor Investors List | View List |
Accretion Pharmaceuticals IPO Important Dates
The following table gives all important events and their timelines for Accretion Pharmaceuticals IPO.
| Anchor Investors Bid Date | 13 May 2025 |
| IPO Open Date | 14 May 2025 |
| IPO Close Date and Time | 16 May 2025 at 3:15 PM |
| Basis of Allotment | 19 May 2025 at 9:00 PM |
| Refunds | 20 May 2025 |
| Credit to DEMAT | 20 May 2025 |
| IPO Listing Date | 21 May 2025 |
About Accretion Pharmaceuticals Limited Company
The Accretion Pharmaceuticals Limited company was founded in year 2012, by Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati. They came together to establish a pharmaceutical manufacturing unit, with vision to provide health care products that match international quality standards at competitive pricing. The Company’s manufacturing facility is currently located in Ahmedabad, Sanand, Gujarat.
At present, the company is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, it also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. Its business is majorly carried out on a principle-to-principle basis with different marketers.
Accretion Pharmaceuticals IPO Listing Status FAQs
-
What is the Listing Date of Accretion Pharmaceuticals IPO?
Accretion Pharmaceuticals IPO Listing Date is 21 May 2025.
-
Can I sell my Accretion Pharmaceuticals IPO allotted shares before listing?
No. You can sell the allotted Accretion Pharmaceuticals IPO shares only after they get listed.
-
What are the Listing Gains for Accretion Pharmaceuticals IPO?
Shares of Accretion Pharmaceuticals IPO are listed on NSE at ₹79.00 (discount of 21.78%).